Cardiomyocyte sarcolemmal ion channels

Cardiomyocyte sarcolemmal ion channels are a diverse group of pore-forming transmembrane proteins, including voltage-gated sodium (e.g., Nav1.5), calcium (e.g., Cav1.2), and potassium channels (e.g., hERG), that facilitate the movement of ions across the cardiac cell membrane [Grant, 2009]. These channels are fundamental to the generation and propagation of the cardiac action potential, which triggers coordinated myocardial contraction [Nerbonne & Kass, 2005]. The phrase "via extracellular ionic gradients" highlights the critical dependence of these channels on the electrochemical driving force established by ion concentrations in the extracellular fluid; for instance, extracellular potassium levels significantly influence the resting membrane potential and channel gating kinetics [Roden, 2014]. Dysregulation of these channels, whether due to genetic mutations (channelopathies) or electrolyte imbalances, is a primary cause of cardiac arrhythmias such as Long QT Syndrome and Brugada Syndrome [PubMed, 11854014]. Pharmacological agents, categorized by the Vaughan Williams classification, target these channels to modulate cardiac rhythm, though they require precise management to avoid secondary rhythm disturbances [StatPearls, NBK538143].

Other names

Cardiac ion channelsSarcolemmal ion channelsVoltage-gated cardiac ion channelsCardiomyocyte sarcolemmal ion channels via extracellular ionic gradients

Modulation of ion conductance (sodium, potassium, or calcium) across the sarcolemma to alter the cardiac action potential duration, conduction velocity, and refractoriness [StatPearls, NBK538143].